Logo
Euro Gen AOD 9604, 5mg

Euro Gen AOD 9604, 5mg

Euro-Gen

Research chemical / peptide reagent
  • Supplied and labelled as a research Use Only peptide, not as a medicinal product, medical device, cosmetic, or food.
  • Not approved by the MHRA, EMA, FDA or other medicines regulators for treatment of obesity, metabolic disease, or any other medical indication.
  • Subject to general chemical and biological safety regulations applicable to laboratory research reagents in the jurisdiction of use.
  • Researchers remain responsible for ensuring compliance with institutional ethics, local laws, and anti Doping codes where applicable.
Synthetic peptide (GH fragment 176-191) for in vitro research

Description

Euro-Gen AOD 9604, 5mg is a synthetic research peptide supplied as a lyophilised powder in a sealed vial, intended strictly for in vitro testing and laboratory research. AOD-9604 is a modified 16-amino-acid fragment of human growth hormone (GH fragment 176–191) derived from the C-terminus of the hGH molecule. It has been investigated in preclinical and early clinical research for its effects on fat metabolism and related metabolic pathways, as well as potential roles in cartilage and tissue repair. The Euro-Gen product is marketed as a high-purity (>99%) peptide for research use only; it is not an approved medicine, food, or cosmetic and is not for human or veterinary administration.

Bnefits

  • Provides a synthetic AOD-9604 peptide corresponding to the C-terminal fragment (GH 176–191) of human growth hormone for controlled laboratory studies.
  • Supplied as a defined 5 mg quantity of lyophilised peptide per vial for reproducible experimental design.
  • Manufactured and quality-controlled in the UK, with batches laboratory tested and marketed as >99% purity for research applications.
  • Backed by a growing body of preclinical and early clinical literature exploring AOD-9604’s effects on fat metabolism, energy balance, and tissue repair, facilitating translational research projects.
  • Clearly labelled and restricted to research use only, helping laboratories maintain separation between experimental reagents and regulated medicinal products.
  • Packaged for convenient storage, transport, and integration into peptide research workflows (e.g. analytical, cell-based, or preclinical models).

Indications

  • No approved therapeutic indications; this product is not licensed as a medicine or medical device.
  • Intended exclusively for in vitro and laboratory research, such as studies on fat metabolism, obesity models, cartilage and joint biology, or growth hormone fragment signalling pathways.
  • May be used as a reference or tool compound in analytical, biochemical, cellular, or preclinical animal research conducted under appropriate institutional and ethical approvals.
  • Not for human or veterinary use, injection, ingestion, or any other form of bodily administration.

Composition

  • Active research ingredient: AOD-9604 peptide (synthetic fragment of human growth hormone, amino acids 176–191 with N-terminal tyrosine substitution).
  • Empirical formula of AOD-9604: C78H123N23O23S2.
  • Peptide sequence (one-letter code): YLRIVQCRSVEGSCGF.
  • Supplied as lyophilised (freeze-dried) peptide powder; specific excipients (if any) are not disclosed by the supplier and may vary by batch.
  • No preservatives, solvents, or reconstitution medium included in the vial; any diluents are supplied separately by the laboratory if required.

Formulation

  • Lyophilised synthetic peptide in a sterile, sealed glass vial, nominal content 5 mg AOD-9604.
  • Research-grade peptide intended for reconstitution with an appropriate laboratory-grade solvent or buffer by qualified personnel, according to institutional protocols.
  • Manufactured and batch tested to high purity (marketed as >99% by HPLC) suitable for in vitro and preclinical research applications.
  • For research use only; not formulated, packaged, or labelled as a medicinal product, food, dietary supplement, or cosmetic.

Packaging

  • Single 5 mg lyophilised peptide vial labelled as Euro-Gen AOD 9604, 5mg, with brand and product identification.
  • Vial presented in secondary packaging suitable for shipment (e.g. cardboard carton or padded container) with temperature and handling guidance as applicable.
  • Accompanied by online product information detailing research-only status, purity claims, structural summary and basic safety disclaimers.
  • Outer and/or online labelling clearly stating: "For research use only. Not for human or veterinary use" (or equivalent wording).

Usage

  • For in vitro and laboratory research use only; to be handled exclusively by suitably qualified and authorised personnel in an appropriate laboratory environment.
  • Do not use in humans or animals by any route of administration; any form of bodily introduction is expressly prohibited by the supplier.
  • Follow institutional and local regulations for handling synthetic peptides, including use of appropriate personal protective equipment (PPE) and engineering controls.
  • If reconstitution is required for experimental procedures, use only suitable sterile laboratory-grade solvents or buffers and follow internal SOPs for peptide handling and disposal.
  • Do not rely on marketing materials for medical decision-making; AOD-9604 is not approved as a treatment for obesity, metabolic disease, or any other condition.
  • Dispose of unused product, solutions and waste material as chemical/biological laboratory waste according to institutional and national regulations.

Contraindications

  • Use in humans or animals (by injection, ingestion, inhalation, topical application, or any other route) is contraindicated and explicitly prohibited by the supplier.
  • Should not be used as a substitute for any approved medicinal product or weight-management therapy.
  • Contraindicated in settings that cannot provide appropriate laboratory safety controls, waste handling, and compliance with research regulations.
  • Should not be handled by untrained personnel, minors, or individuals without appropriate laboratory safety training.
  • Not to be used in competitive athletes or any context aiming to circumvent anti-doping rules; AOD-9604 and related growth hormone fragments are subject to anti-doping prohibitions in sport.

Adverse Effects

  • Because this product is not intended for human or veterinary use, no formal adverse effect profile is established for this commercial preparation.
  • Accidental exposure (e.g. skin contact, inhalation of dust/aerosol, or eye contact) may cause non-specific irritation or sensitisation; standard laboratory first-aid measures (rinsing, seeking medical evaluation) should be followed.
  • Ingestion or injection of research-grade AOD-9604 by humans or animals may pose unpredictable risks due to absence of regulatory oversight on quality, sterility, dosing, and long-term safety; such use is expressly discouraged and falls outside intended use.
  • Laboratory workers with known hypersensitivity to peptides or excipients should minimise exposure and use appropriate PPE; any suspected reaction should be evaluated by occupational health or a medical professional.

Storage Conditions

  • Store the unopened vial in a cool, dry place, protected from direct light and moisture, in accordance with the supplier’s guidance.
  • Typically, lyophilised research peptides are stored refrigerated (e.g. 2–8 °C) or frozen (e.g. ≤ −20 °C) to maximise stability; follow your laboratory’s peptide storage SOPs.
  • Keep vial tightly sealed until use to minimise exposure to humidity and environmental contaminants.
  • Avoid repeated freeze–thaw cycles of any reconstituted solutions; prepare aliquots if longer-term storage of solutions is required within your institutional guidelines.
  • Store out of reach of unauthorised personnel and clearly segregated from any products intended for human or veterinary use.
  • Observe and comply with any expiry or best-before dates and batch information provided by the supplier.

Duration

Not applicable. Euro-Gen AOD 9604, 5mg is a research reagent with no approved therapeutic use or treatment regimen; any exposure of humans or animals is outside the stated and permitted use.

Onset

Not applicable for clinical use. In the research literature, AOD-9604 has been studied for its biochemical and physiological effects on fat metabolism and tissue models, but these findings do not constitute approved clinical efficacy or dosing guidance.

Browse more Research chemical / peptide reagent

Top Treatments

Top Cities in the UK